| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids | $ Total Asks | # Bids | # Asks | Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Medallia | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $338.37MM | Series F | 2/25/2019 | $70MM | $2.44B | $15.00 | RGM Capital, Sequoia Capital, Wasatch Advisorss | ||||
 | Duolingo | Education E-Learning | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $183.3MM | Series H | 11/18/2020 | $35MM | $2.42B | $59.77 | Durable Capital Partners, General Atlantic | ||||
 | Generate Biomedicines | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $812.92MM | Series C | 1/21/2025 | $399.4MM | $2.22B | $11.85 | Amgen, Nvidia, MAPS Capital, Pictet Alternative Advisors, Flagship Pioneering, Abu Dhabi Investment Authority, Fidelity, T. Rowe Price, ARCH Venture Partners, March Capital, Alaska Permanent Fund, Altitude Life Science Ventures, Novartis | ||||
 | MNTN | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $358.43MM | Series D | 2/1/2022 | $119MM | $2.21B | $22.97 | BlackRock, Fidelity | ||||
 | AvidXchange | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $759.17MM | Senior Preferred | 1/17/2020 | $130MM | $2.21B | $47.76 | Sixth Street Partners | ||||
 | Allbirds | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $253.27MM | Series E | 9/28/2020 | $100MM | $2.17B | $11.56 | Franklin Templeton, T. Rowe Price, Baillie Gifford, TDM Growth Partners, Rockefeller Capital Management | ||||
 | Lemonade | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $354.84MM | Series D | 7/9/2019 | $175MM | $2.1B | $42.21 | SoftBank, GV, Allianz X, OurCrowd, Thrive Capital, General Catalyst | ||||
 | C3.ai (C3 IoT) | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $786.96MM | Series H | 8/14/2019 | $50MM | $2.09B | $30.23 | BlackRock | ||||
 | Zymergen | Industrial Materials | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $1.84B | Series D | 9/8/2020 | $300MM | $2.07B | $22.33 | SoftBank, Baillie Gifford, Baron Funds, DCVC, Perceptive Adivsors, True Ventures | ||||
 | Cloudflare | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $222.1MM | Series D | 6/19/2015 | $150MM | $1.9B | $11.00 | Fidelity Investments, CapitalG, Microsoft, Baidu, Qualcomm Ventures, Greenspring Associates, New Enterprise Associates, Venrock, Pelion Venture Partners, Union Square Ventures | ||||
 | Marqeta | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $378.77MM | Series E | 5/21/2019 | $260.01MM | $1.89B | $3.89 | Coatue Management, CommerzVentures, Visa Ventures, Vitruvian Partners, IA Capital Group, CreditEase, Granite Ventures, Commerce Ventures, 83North, Spark Capital, Goldman Sachs Investment Partners, Geodesic Capital, Lone Pine Capital, ICONIQ Capital | ||||
 | Sweetgreen | Consumer & Lifestyle Restaurants & Coffee | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $672.21MM | Series J | 1/21/2021 | $156MM | $1.86B | $17.10 | Undisclosed Investors | ||||
 | Eikon Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $1.16B | Series D | 2/14/2025 | $350.7MM | $1.85B | $5.84 | Lux Capital, Alexandria Venture Investments, AME Cloud Ventures, The Column Group, E15 VC, Foresite Capital, General Catalyst, Soros Capital, StepStone Group, T. Rowe Price, UC Investments | ||||
 | ACV Auctions | Consumer & Lifestyle E-commerce | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $366.9MM | Series E-1 | 10/15/2020 | $55MM | $1.8B | $11.85 | Durable Capital Partners, Bessemer Venture Partners | ||||
 | Warby Parker | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $293.93MM | Series E | 3/7/2018 | $75MM | $1.75B | $15.72 | T. Rowe Price | ||||
 | Asana | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $214.51MM | Series E-1 | 11/29/2018 | $25.5MM | $1.61B | $8.19 | 8VC, Founders Fund, Benchmark Capital, Generation Investment Management, Lead Edge Capital, World Innovation Lab | ||||
 | Alkami Technology | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $370.12MM | Series F | 9/29/2020 | $140MM | $1.51B | $16.00 | D1 Capital Partners, Fidelity, Franklin Templeton, Stockbridge Investors | ||||
 | Vroom | Consumer & Lifestyle E-commerce | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $726.07MM | Series H | 12/6/2019 | $254.37MM | $1.51B | $27.19 | Durable Capital Partners, T. Rowe Price, L Catterton, Constitution Capital Partners | ||||
 | One Medical Group | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $437.68MM | Series I | 8/22/2018 | $250MM | $1.5B | $12.43 | The Carlyle Group | ||||
 | Beyond Meat | Foodtech Animal-Free Protein | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $194.81MM | Series H | 11/2/2018 | $50MM | $1.41B | $24.23 | Unknown Investors | ||||
 | Wealthfront | Fintech Capital Markets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $300.01MM | Series H-2 | 9/2/2022 | $34.85MM | $1.4B | $9.54 | UBS | ||||
 | Cava | Consumer & Lifestyle Restaurants & Coffee | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $1.64B | Series F | 4/27/2021 | $212MM | $1.39B | $12.54 | T. Rowe Price Group, Equilibra Partners Management, Lighthouse Investment Partners, Declaration Partners | ||||
 | Adaptive Biotechnologies | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $561.37MM | Series F-1 | 1/4/2018 | $45MM | $1.35B | $10.67 | Microsoft | ||||
 | 10x Genomics, Inc. | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $xx.xx | $xx.xx | xx | xx | Not available | -- | -- | $222.59MM | Series D-1 | 1/7/2019 | $35MM | $1.34B | $12.73 | Meritech Capital, Fidelity, Wells Fargo | ||||